Xtant Medical Holdings (XTNT) Raw Materials (2019 - 2025)

Xtant Medical Holdings (XTNT) has reported Raw Materials for 7 consecutive years, with $5.7 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Raw Materials fell 14.09% year-over-year to $5.7 million in Q4 2025; TTM through Dec 2025 was $5.7 million, a 14.09% decrease from a year earlier, with the FY2025 full-year figure at $5.7 million, down 14.09% from the prior year.
• Raw Materials was $5.7 million for Q4 2025 at Xtant Medical Holdings, up from $5.6 million in the prior quarter.
• Over five years, Raw Materials peaked at $7.3 million in Q4 2023 and troughed at $3.8 million in Q1 2021.
• A 5-year average of $5.8 million and a median of $5.7 million in 2022 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials surged 49.4% in 2021 and fell 23.22% in 2025, its largest moves.
• Over 5 years, Raw Materials stood at $5.6 million in 2021, then climbed by 0.27% to $5.6 million in 2022, then increased by 29.16% to $7.3 million in 2023, then decreased by 8.9% to $6.6 million in 2024, then slipped by 14.09% to $5.7 million in 2025.
• The last three Raw Materials figures came in at $5.7 million (Q4 2025), $5.6 million (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.